A complete mutational fitness map of the hepatitis C virus nonstructural 3 protease: Relation to recognition by cytotoxic T lymphocytes

Journal of Infectious Diseases

Volumn 194, Issue 12, 2006, Pages 1724-1728

  Söderholm, Jonas ^a   Sällberg, Matti ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; EPITOPE; GLYCINE; HYBRID PROTEIN; NONSTRUCTURAL PROTEIN 3; PEPTIDE; PROTEINASE; VIRUS PROTEIN;

ARTICLE; CYTOTOXIC T LYMPHOCYTE; GENE MUTATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIDE ANALYSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; VIRUS GENOME; VIRUS HEPATITIS; VIRUS REPLICATION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CYSTEINE ENDOPEPTIDASES; EPITOPES; GENES, VIRAL; HEPACIVIRUS; HEPATITIS C; HLA-A2 ANTIGEN; HUMANS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTAGENESIS; SPECIES SPECIFICITY; SPLEEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VARIATION (GENETICS); VIRAL NONSTRUCTURAL PROTEINS; VIRAL PROTEINS;

EID: 33845381987     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/509513     Document Type: Article

References (15)

1. Erickson AL, Kimura Y, Igarashi S, et al. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 2001; 15:883-95.
2. Ray SC, Fanning L, Wang XH, Netski DM, Kenny-Walsh E, Thomas DL. Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. J Exp Med 2005; 201:1753-9.
3. Gale M Jr, Foy EM. Evasion of intracellular host defense by hepatitis C virus. Nature 2005; 436:939-45.
4. Frelin L, Brenndorfer ED, Ahlen G, et al. The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor α mediated liver disease. Gut 2006; 55:1475-83.
5. Soderholm J, Ahlen G, Kaul A, et al. Relation between viral fitness and immune escape within the hepatitis C virus protease. Gut 2006; 55:266-74.
6. Frelin L, Ahlen G, Alheim M, et al. Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene. Gene Ther 2004; 11:522-33.
7. Cerny A, McHutchison JG, Pasquinelli C, et al. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest 1995; 95:521-30.
8. Martin P, Parroche P, Chatel L, et al. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen. J Mod Virol 2004; 74:397-405.
9. Sallberg M, Ruden U, Magnius LO, Norrby E, Wahren B. Rapid "tea-bag" peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins. Immunol Lett 1991; 30:59-68.
10. Stuber G, Modrow S, Hoglund P, et al. Assessment of major histocompatibility complex class I interaction with Epstein-Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading-deficient cells. Eur J Immunol 1992; 22:2697-703.
11. Kim JL, Morgenstern KA, Lin C, et al. Crystal structure of the hepatitis C virus NS3 protease domain completed with a synthetic NS4A cofactor peptide. Cell 1996; 87:343-55.
12. Yi M, Tong X, Skelton A, et al. Mutations conferring resistance to SCH6, a novel hepatitis C virus NS3/4A protease inhibitor: reduced RNA replication fitness and partial rescue by second-site mutations. J Biol Chem 2006; 281:8205-15.
13. Meylan E, Curran J, Hofmann K, et al. Cardif is an adaptor protein in the RIG-1 antiviral pathway and is targeted by hepatitis C virus. Nature 2005; 437:1167-72.
14. Ahlén G, Nyström J, Pult I, Frelin L, Hultgren C, Sällberg M. In vivo clearance of hepatitis C virus nonstructural 3/4A-expressing hepatocytes by DNA vaccine-primed cytotoxic T lymphocytes. J Infect Dis 2005; 192:2112-6.
15. Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005; 11:791-6.